These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981 [TBL] [Abstract][Full Text] [Related]
10. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Mazya MV; Ahmed N; Ford GA; Hobohm C; Mikulik R; Nunes AP; Wahlgren N; Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971 [TBL] [Abstract][Full Text] [Related]
11. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683 [TBL] [Abstract][Full Text] [Related]
12. Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME. Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; de Rochemont Rdu M; Singer OC; Bammer R; Saver JL Ann Neurol; 2016 Jan; 79(1):76-89. PubMed ID: 26476022 [TBL] [Abstract][Full Text] [Related]
13. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877 [TBL] [Abstract][Full Text] [Related]
14. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Mazya M; Egido JA; Ford GA; Lees KR; Mikulik R; Toni D; Wahlgren N; Ahmed N; Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178 [TBL] [Abstract][Full Text] [Related]
15. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Dzialowski I; Pexman JH; Barber PA; Demchuk AM; Buchan AM; Hill MD; Stroke; 2007 Jan; 38(1):75-9. PubMed ID: 17122437 [TBL] [Abstract][Full Text] [Related]
16. Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke. Barreto AD; Fanale CV; Alexandrov AV; Gaffney KC; Vahidy FS; Nguyen CB; Sarraj A; Rahbar M; Grotta JC; Savitz SI; Ann Neurol; 2016 Aug; 80(2):211-8. PubMed ID: 27273860 [TBL] [Abstract][Full Text] [Related]
17. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Whiteley WN; Emberson J; Lees KR; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis S; Donnan G; Grotta J; Howard G; Kaste M; Koga M; von Kummer R; Lansberg MG; Lindley RI; Lyden P; Olivot JM; Parsons M; Toni D; Toyoda K; Wahlgren N; Wardlaw J; Del Zoppo GJ; Sandercock P; Hacke W; Baigent C; Lancet Neurol; 2016 Aug; 15(9):925-933. PubMed ID: 27289487 [TBL] [Abstract][Full Text] [Related]
18. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase. Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S; J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309 [TBL] [Abstract][Full Text] [Related]
19. Hypoattenuation on CT angiographic source images predicts risk of intracerebral hemorrhage and outcome after intra-arterial reperfusion therapy. Schwamm LH; Rosenthal ES; Swap CJ; Rosand J; Rordorf G; Buonanno FS; Vangel MG; Koroshetz WJ; Lev MH AJNR Am J Neuroradiol; 2005 Aug; 26(7):1798-803. PubMed ID: 16091532 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis. Shin DH; Kang MJ; Kim JW; Shin DJ; Park HM; Sung YH; Kim EY Cerebrovasc Dis; 2017; 44(5-6):241-247. PubMed ID: 28848080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]